TELA Bio shares are trading higher after the company announced it has taken actions to reduce its annual operating expenses by approximately $17.0 million across the organization, driven by a targeted headcount reduction of approximately 20%.

TELA Bio Announces $17M Annual Expense Reduction Through 20% Workforce Streamlining and Resource Optimization, Extending Cash Runway Into 2028

TELA Bio COO And CFO Roberto Cuca To Step Down Effective Immediately

8-K filing — TELA Bio, Inc. (TELA)

Filed: 2026-08-31 AccNo: 0001104659-26-103548 Size: 237 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits